| Drug Name: | Atovaquone (95233-18-4) |
|---|---|
| PubChem ID: | 74989 |
| SMILES: | C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O |
| InchiKey: | BSJMWHQBCZFXBR-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Infective Agents, Antimalarials, Antiparasitic Agents, Antiprotozoal Agents, Enzyme Inhibitors |
| Molecular Weight (dalton) | : | 366.844 |
| LogP | : | 5.3485 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 54.37 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Etoposide (33419-42-0) | Acute Myeloid Leukaemia | Synergistic | Unclear | The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category